A negative aspect of the patent system is the controversy and dispute that follows patent distribution of benefits. We can expect that there will also be challengers regarding the recipient of prize payments, thus the prize system has to specify how to resolve disputes, and also develop a thorough screening mechanism to confirm the reported benefits of the invented drug.
<section_begin=Patent_Reform/>
=Patent Reform=
*[[The Shield Act]]
*[[Patent Fee Integrity Act]]
<section_end=Patent_Reform/>